Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease

Journal of the American Society of Nephrology

Volumn 11, Issue 5, 2000, Pages 912-916

  Foley, Robert N ^a,d   Parfrey, Patrick S ^a   Kent, Gloria M ^a   Harnett, John D ^a   Murray, David C ^b   Barre, Paul E ^c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Divisions Nephrology Salvation A   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIALYSIS; DISEASE MARKER; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0034056792     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v115912     Document Type: Article

References (35)

1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
2. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290, 1989
3. Huting J, Alpert MA: Course of left ventricular diastolic dysfunction in end-stage renal disease on long-term continuous ambulatory peritoneal dialysis. Clin Nephrol 39: 81-87, 1993
4. Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P: Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 45: 104-110, 1996
5. London GM, Fabiani F, Marchais SJ, de Vernejoul MC, Guerin AP, Safar ME, Metivier F, Llach F: Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 31: 973-980, 1987
6. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 28: 53-61, 1996
7. Huting J, Kramer W, Schutterle G, Wizemann V: Analysis of left ventricular changes associated with chronic hemodialysis: A non-invasive follow-up study. Nephron 49: 284-290, 1988
8. Huting J, Kramer W, Reitinger J, Kuln K, Wizemann V, Schut terle G: Cardiac structure and function in continuous ambulatory dialysis: Influence of blood purification and hypercirculation. Am Heart J 119: 244-352, 1990
9. London GM, Zins B, Pannier B, Naret C, Berthelot JM, Jacquot C, Safar M, Drueke TB: Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 36: 878-882, 1989
10. Low I, Grutzmacher P, Bergmann M, Schoeppe W: Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin. Clin Nephrol 31: 26-30, 1989
11. Macdougall IC, Lewis NP, Saunders MJ, Cochlin DL, Davies ME, Hutton RD, Fox KA, Coles GA, Williams JD: Long-term cardiorespiratory effect of amelioration of renal anaemia by erythropoietin. Lancet 335: 489-493, 1990
12. Silberberg J, Racine N, Barre PE, Sniderman AD: Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 6: 1-4, 1990
13. Low-Friedrich I, Grutzmacher P, Marz W, Bergmann M, Schoeppe W: Therapy with recombinant human erythropoietin reduces cardiac size and improves cardiac function in chronic hemodialysis patients. Am J Nephrol 11: 54-60, 1991
14. Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J: Regression of left ventricular hypertrophy after partial correction of anaemia with erythropoietin in patients on hemodialysis: A prospective study. Clin Nephrol 35: 280-287, 1991
15. Tagawa H, Nagano M, Saito H, Umezu M, Yamakado M: Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: Proposal for a hematocrit most beneficial to hemodynamics. Clin Nephrol 35: 35-38, 1991
16. Goldberg N, Lundin AP, Delano B, Friedman EA, Stein RA: Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am Heart J 124: 424-427, 1992
17. Martinez-Vea A, Bardaji A, Garcia C, Ridao C, Richart C, Oliver JA: Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis 19: 353-357, 1992
18. Fellner SK, Lang RM, Neumann A, Korcarz C, Borow KM: Cardiovascular consequences of the correction of the anemia of renal failure with erythropoietin. Kidney Int 44: 1309-1315, 1993
19. Morris KP, Skinner JR, Hunter S, Coulthard MG: Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end-stage renal failure. Arch Dis Child 68: 644-648, 1993
20. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49: 1379-1385, 1996
21. Conlon PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ: Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 7: 2658-2663, 1996
22. Devereux RB, Pini R, Aurigemma GP, Roman MJ: Measurement of left ventricular mass: Methodology and expertise. J Hypertens 15: 801-809, 1997
23. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 90: 1786-1793, 1994
24. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Reboldi G, Porcellati C: Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97: 48-54, 1998
25. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57: 450-458, 1986
26. Pombo JF, Troy BL, Russell RO Jr: Left ventricular volumes and ejection fraction by echocardiography. Circulation 43: 480-490, 1971
27. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 7: 728-736, 1996
28. Hutchinson TA, Thomas DC, MacGibbon B: Predicting survival in adults with end-stage renal disease: An age equivalence index. Ann Intern Med 96: 417-423, 1982
29. U.S. Renal Data System: U.S. Renal Data System 1992 Annual Report. IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20[Suppl 2]: 32-38, 1992
30. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47: 884-890, 1995
31. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990
32. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352, 1991
33. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 117: 831-836, 1992
34. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RS, Junor BJ, McMillan MA, Briggs JD: Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 13: 1499-1505, 1998
35. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024-2031, 1995